Sabra Health Care Reit, INC

Sabra Health Care REIT announced a business update, including a significant re-tenanting of 26 Avamere properties and increased full-year 2026 guidance.

Sabra Health Care REIT, Inc. announced the results of its annual meeting, including the election of directors and ratification of its auditor.

Sabra Health Care REIT provides a strategic update on its portfolio, investment activity, and balance sheet strength as of May 2026.

Sabra Health Care REIT, Inc. announced robust first quarter 2026 results, driven by strong operational performance and strategic investments, while reiterating its full-year guidance.

Sabra Health Care REIT, Inc. announced robust fourth-quarter 2025 results and introduced optimistic 2026 guidance, driven by strong investment activity and operational improvements across its portfolio.

Sabra Health Care REIT, Inc. announced the appointment of Darrin Smith as Chief Investment Officer, Secretary, and Executive Vice President, succeeding the retiring Talya Nevo-Hacohen.

Sabra Health Care REIT, Inc. reports significant nine-month net income and FFO growth, driven by strategic acquisitions and debt refinancing, despite a quarterly dip in net income.

Sabra Health Care REIT announced significant increases in net income and FFO per share for Q2 2025, driven by strategic acquisitions, dispositions, and effective debt management.

Sabra Health Care REIT's Q1 2025 results show increased revenue driven by growth in resident fees and services, particularly in the Senior Housing Managed portfolio.

Sabra Health Care REIT announced its third-quarter 2024 results, showing a net income of $29.8 million, a significant improvement compared to a net loss in the same period last year.

Sabra Health Care REIT's second quarter results show a net income increase, offset by impairment charges and ongoing portfolio adjustments.

Sabra Health Care REIT announced its first quarter 2024 results, showing a net income of $26.3 million, a significant improvement compared to a net loss in the same period last year.

Sabra Health Care REIT's 2024 10-K filing reveals a year of strategic portfolio management, highlighting both growth in key areas and challenges in the healthcare property sector.

Sabra Health Care REIT discloses its director compensation policy effective March 21, 2023, and files its annual report on Form 10-K for the year ended December 31, 2023.

Richard K Matros, Chair, CEO and President and a Director of Sabra Health Care REIT, Inc., sold 200,000 shares of common stock on September 8, 2026 for $20.83 per share.

Darrin Smith, Executive VP, CIO & Secretary of Sabra Health Care REIT, Inc., received 495 shares of common stock on August 31, 2026.

Jeffrey A. Malehorn, a Director of Sabra Health Care REIT, Inc., received 791 shares of common stock on August 31, 2026.

Ann Kono, a Director of Sabra Health Care REIT, Inc., received 791 shares of common stock on August 31, 2026.

Lynne S Katzmann, a Director of Sabra Health Care REIT, Inc., received 791 shares of common stock on August 31, 2026.

Michael J Foster, a Director of Sabra Health Care REIT, Inc., received 791 shares of common stock on August 31, 2026.

Sabra Health Care REIT, Inc. has announced its 2026 Annual Meeting of Stockholders, set for June 17, 2026, to elect directors, ratify auditor appointment, and vote on executive compensation.

Sabra Health Care REIT, Inc. is set to hold its annual stockholder meeting on June 12, 2025, with voting open for the election of directors, ratification of the company's accounting firm, and approval of executive compensation.

Sabra Health Care REIT will hold its 2025 Annual Meeting of Stockholders on June 12, 2025, to vote on director elections, ratification of the accounting firm, and executive compensation.

Sabra Health Care REIT is holding its annual stockholder meeting on June 13, 2024, and provides information on how to vote on key proposals.

Sabra Health Care REIT's 2024 Annual Meeting of Stockholders will address director elections, auditor ratification, and executive compensation.

Vanguard Capital Management has reported beneficial ownership of over 13.3 million shares, representing 5.28% of the outstanding common stock of Sabra Health Care REIT Inc.

Vanguard Portfolio Management has reported a beneficial ownership of 23,239,071 shares, representing 9.21% of the outstanding common stock of Sabra Health Care REIT Inc.

The Vanguard Group reports 0% beneficial ownership of Sabra Health Care REIT Inc. common stock following an internal realignment.

State Street Corporation has reported a 4.8% beneficial ownership stake in Sabra Health Care REIT Inc. as of December 31, 2025.

Principal Real Estate Investors LLC and Principal Global Investors collectively report a 9.9% beneficial ownership in Sabra Health Care REIT, Inc. common stock.

Principal Real Estate Investors and Principal Global Investors have disclosed a combined 8.7% beneficial ownership in Sabra Health Care REIT, Inc.